Navigation Links
H3 Biomedicine and BGI Announce Collaboration to Develop and Share Crucial Cancer Genomic Sequencing Data
Date:3/21/2013

ized medicines, especially for those people living with cancers for which there are, today, limited treatment options."

Recent advances in human cancer genomics have revealed novel cancer target opportunities that will enable personalized cancer medicine approaches. Many of the identified recurrent gene mutations exist at low frequencies and the information necessary to select relevant pre-clinical models to study these mutations does not exist. Under the partnership announced today, BGI will sequence 250 cancer cell lines via next-generation, whole exome sequencing in this first study. H3 Biomedicine and BGI will jointly analyze the data to deliver a highly curated set of genetically profiled, pre-clinical model information that will help to accelerate drug discovery and development efforts.

Yingrui Li , chief executive officer of BGI Americas, said, "We are pleased to collaborate with H3 Biomedicine, and to have this opportunity to apply our state-of-the-art, next-gen sequencing capabilities and bioinformatics expertise to help advance the discovery of novel cancer drug targets and full-scale pharmacogenomics findings. I believe this partnership will yield significant, valuable genomic information that will lay a solid foundation for developing pre-clinical cancer models and new anticancer drugs to benefit human health. BGI, in keeping with our global legacy of collaborative, published research, including our participation in ICGC, looks forward to partnering with H3 Biomedicine in developing and sharing this genomic data with the international research community."

About H3 Biomedicine Inc.
H3 Biomedicine is a biopharmaceutical company specializing in the discovery and development of oncology treatments. Using modern synthetic chemistry, chemical biology and human genetics, the company seeks to bring the next generation of cancer treatments to market with the goal of improvi
'/>"/>

SOURCE H3 Biomedicine Inc.
Copyright©2012 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related medicine technology :

1. Cellular Biomedicine Group Marks the Launch of China Clinical Trial for TC-DC Therapy for Hepatocellular Carcinoma
2. EastBridge Investment Group Announces Merger with Cellular Biomedicine Group
3. Ohr Pharmaceutical Announces Results from OHR/AVR118 Phase II Trial in Cancer Cachexia
4. Elbit Imaging Announces Receipt of an Acceleration Notice from Bank Leumi
5. Hologic Announces Completion of Loan Repricing
6. Meridian Health Plan Announces New Pharmacy Benefit Manager
7. GS Medical USA announces FY2012 record year-end sales growth of over 130% over FY2011
8. ENCO Pharmaceutical Development Announces Another Successful FDA Inspection - Its 2nd This Year
9. Research and Markets Announces the Release of Autoimmune Disease Therapeutics to 2016. Targets, Technologies, Therapies, Markets and Opportunities
10. Harwood Feffer LLP Announces Investigation of Spectrum Pharmaceuticals, Inc.
11. EGEN, Inc. Announces a Phase I Clinical Trial for Advanced Ovarian Cancer
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:7/10/2014)... CARLSBAD, Calif. , July 10, 2014 /PRNewswire/ ... products and services, has launched the FreeRunner™ knee ... runners, who suffer from patella mal-tracking return to ... anatomy differently than other braces, providing support when ... move normally when they don,t. Patellofemoral ...
(Date:7/10/2014)... -- Valeant Pharmaceuticals International, Inc. (NYSE: VRX ... sale to Galderma of all rights to Restylane, Perlane, ... for $1.4 billion in cash, pursuant to the previously ... acquisition of Galderma. "We are pleased ... company that is firmly committed to the aesthetic dermatology ...
(Date:7/10/2014)... -- Decision Resources Group finds that over half of ... Drug Administration,s (FDA) approval of Vifor Fresenius Medical Care ... by the FDA in November 2013 for the treatment ... dialysis. Other key findings from the report ... : , Bundling: Based ...
Breaking Medicine Technology:Breg Introduces Knee Brace to Help Runners with Patellofemoral Pain Syndrome 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 2Half of Surveyed Nephrologists Report Moderate Familiarity with Velphoro, Which Received FDA Approval Late Last Year for the Treatment of Hyperphosphatemia in Dialysis 3
... 2011 Researchers presented data demonstrating increased specificity ...  MRI for the detection of breast cancer at ... National Interdisciplinary Breast Center Conference held March 12 ... poster presentation, titled Pre-Surgical Detection of Malignancies ...
... Varian Medical Systems (NYSE: VAR ) announced ... fiscal year 2011 following the close of regular trading on ... by a teleconference available to all interested parties at 2:00 ... conference call webcast will be available on the company website ...
Cached Medicine Technology:Researchers Present Key Findings Comparing PEM to MRI for Identification of Contralateral Breast Cancer at the National Consortium of Breast Centers (NCBC) Conference 2Varian Medical Systems Schedules Second Quarter FY2011 News Release and Conference Call 2
(Date:7/10/2014)... York, US (PRWEB) July 10, 2014 ... , Merrill DataSite recently streamed the live webinar ‘Capitalizing ... a discussion from a group of several M&A experts ... seeing in the broader energy transaction marketplace. These experts ... and how the deal market in this sector has ...
(Date:7/10/2014)... July 10, 2014 CBPartners, a global ... has launched a new website. The redesigned site ... increased access to the firm’s thought pieces, blog posts, ... ideal platform to showcase our insights, capabilities, and to ... CBPartners’ Chief Executive Officer, Cyrus Chowdhury. “An enhanced ...
(Date:7/10/2014)... July 10, 2014 Best ... believes that having family close by during a ... in whether or not the process is successful, ... its website at http://www.bestdrugrehabilitation.com/success-stories/ . , The ... video testimonials from several Best Drug Rehabilitation graduates ...
(Date:7/10/2014)... Washington, New York (PRWEB) July 10, 2014 ... firm dedicated to protecting the rights of victims ... couple has brought a lawsuit over allegations that ... her body by a power morcellator used during ... has been filed against Richard Wolf Medical Instruments ...
(Date:7/10/2014)... A new study from Colorado School of Public Health ... remains a major problem in the Navajo Nation and ... Native Americans is abysmal with more than three times ... Terrence Batliner, DDS, MBA, associate director of the Center ... Public Health. "The number one problem is access to ...
Breaking Medicine News(10 mins):Health News:Register to Download Merrill DataSite's Report: Capitalizing on the Shifting Sands of the Energy Market 2Health News:CBPartners Announces New Website 2Health News:Best Drug Rehabilitation Launches New Success Stories Section of Website 2Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 2Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 3Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 4Health News:Couple Sues Over Alleged Cancer Risk Associated with use of a Power Morcellator During the Woman's Laparoscopic Fibroid Removal Procedure, Parker Waichman Comments 5Health News:Study finds widespread oral health problems among Navajo 2
... at the Financial Communications Forum, New York, ... named John,Hancock Retirement Plan Service,s "EZ Route" post-enrollment ... Award for Customer Advocacy in,Financial Services. Sponsored by ... at the Financial Communications Forum in New York, ...
... Framework includes sample RFI language, advantages of ... concept, WASHINGTON, April 16 The ... representing the country,s,national business leaders, policymakers and ... for health care purchasers to buy,health care ...
... Mike Roban has been named Vice,President of Sales of ... worldwide emergency assistance and insurance company.,A respected veteran with ... travel assistance services, Roban will add further depth and ... to joining MEDEX Global Group, Roban was the senior ...
... urged all 27 EU countries to continue to seek ... that osteoporosis places on health systems throughout Europe, as ... status of osteoporosis management across member states. , The ... to prepare the report, Osteoporosis in the European Union ...
... by researchers at the Mayo Clinic site in Florida ... largely caused by inherited genetic mutations that pass through ... of years. These genetic influences, which can be small ... that the neurodegenerative disease mostly occurs in a random ...
... ImQuest Life Sciences today,presented important new results ... development candidate, IQP-0410, and lead topical microbicide,development ... Ph.D. (Executive Vice President and Chief Scientific ... Microbicide Research & Development),were invited to speak ...
Cached Medicine News:Health News:John Hancock's 'EZ Route' Post-Enrollment Education Program Wins 2008 Insight Award for Customer Advocacy in Financial Services 2Health News:Patient Centered Primary Care Collaborative Releases New Guidelines for Health Care Purchasers 2Health News:Patient Centered Primary Care Collaborative Releases New Guidelines for Health Care Purchasers 3Health News:Patient Centered Primary Care Collaborative Releases New Guidelines for Health Care Purchasers 4Health News:MEDEX Global Group Hires Industry Veteran Mike Roban as Vice President of Sales 2Health News:IOF calls for concerted support for second EU osteoporosis audit 2Health News:Different mutations in single gene suggest Parkinson's is primarily an inherited genetic disorder 2Health News:Different mutations in single gene suggest Parkinson's is primarily an inherited genetic disorder 3Health News:Different mutations in single gene suggest Parkinson's is primarily an inherited genetic disorder 4Health News:Different mutations in single gene suggest Parkinson's is primarily an inherited genetic disorder 5Health News:ImQuest Presents New Anti-HIV Drug and Topical Microbicide Development Results on Lead Pyrimidinedione Products IQP-0410 and IQP-0528 2
... a completely automated instrument that offers Rapid ... 6 hour same day turnaround), random or ... It is used for bacterial and yeast ... and has a complete data management system. ...
IDS Rapid One, a microbial identification system....
The Cogent Microbial Luminescence System (MLS) is a superior Rapid microbial detection system for UHT product screening combining proven technology of ATP-bioluminescence with unsurpassed hardware in...
... SkanWasher 300 is an ... designed to give reliable, ... cross-contamination between wells, and ... to plate. The washer ...
Medicine Products: